Found: 819
Select item for more details and to access through your institution.
Functional impairment of chronic migraine with medication overuse: Secondary analysis from the Medication Overuse Treatment Strategy (MOTS) trial.
- Published in:
- Headache: The Journal of Head & Face Pain, 2024, v. 64, n. 6, p. 632, doi. 10.1111/head.14732
- By:
- Publication type:
- Article
Sustained response to atogepant in episodic migraine: post hoc analyses of a 12-week randomized trial and a 52-week long-term safety trial.
- Published in:
- Journal of Headache & Pain, 2024, v. 25, n. 1, p. 1, doi. 10.1186/s10194-024-01783-6
- By:
- Publication type:
- Article
Alleviation of migraine related pain and anxiety by inhibiting calcium-stimulating AC1-dependent CGRP in the insula of adult rats.
- Published in:
- Journal of Headache & Pain, 2024, v. 25, n. 1, p. 1, doi. 10.1186/s10194-024-01778-3
- By:
- Publication type:
- Article
Interictal Dysfunctions of Attention, Vigilance, and Executive Functions in Migraine and Their Reversal by Preventive Treatment: A longitudinal Controlled Study.
- Published in:
- Annals of Indian Academy of Neurology, 2024, v. 27, n. 3, p. 254, doi. 10.4103/aian.aian_40_24
- By:
- Publication type:
- Article
Characterizing gaps in the preventive pharmacologic treatment of migraine: Multi‐country results from the CaMEO‐I study.
- Published in:
- Headache: The Journal of Head & Face Pain, 2024, v. 64, n. 5, p. 469, doi. 10.1111/head.14721
- By:
- Publication type:
- Article
Reliability, validity, and responsiveness of the Arabic version of HIT‐6 questionnaire in patients with migraine indicated for preventive therapy: A multi‐center study.
- Published in:
- Headache: The Journal of Head & Face Pain, 2024, v. 64, n. 5, p. 500, doi. 10.1111/head.14719
- By:
- Publication type:
- Article
Implications of high homocysteine levels in migraine pain: An experimental study of the excitability of peripheral meningeal afferents in rats with hyperhomocysteinemia.
- Published in:
- Headache: The Journal of Head & Face Pain, 2024, v. 64, n. 5, p. 533, doi. 10.1111/head.14710
- By:
- Publication type:
- Article
The Effect of Melatonin on Reducing the Frequency and Severity of Migraine Attacks: A Double-Blind, Randomized Clinical Trial.
- Published in:
- Iranian Journal of Medical Sciences, 2024, v. 49, n. 5, p. 313, doi. 10.30476/ijms.2023.97782.2965
- By:
- Publication type:
- Article
Exploring the Impact of Treating Functional Constipation on Headache Episodes in Children Suffering from Migraine.
- Published in:
- Journal of Comprehensive Pediatrics, 2024, v. 15, n. 2, p. 1, doi. 10.5812/jcp-143088
- By:
- Publication type:
- Article
Unsatisfactory response to acute medications does not affect the medication overuse headache development in pediatric chronic migraine.
- Published in:
- Journal of Headache & Pain, 2024, v. 25, n. 1, p. 1, doi. 10.1186/s10194-024-01766-7
- By:
- Publication type:
- Article
An economic evaluation of eptinezumab for the preventive treatment of migraine in the UK, with consideration for natural history and work productivity.
- Published in:
- Journal of Headache & Pain, 2024, v. 25, n. 1, p. 1, doi. 10.1186/s10194-024-01749-8
- By:
- Publication type:
- Article
AbbVie Announces Late Breaking Data at AAN to Support Atogepant Long-Term Safety, Efficacy for Migraine Prevention.
- Published in:
- Patient Care (Online), 2024, p. 1
- By:
- Publication type:
- Article
Consider CGRP Inhibitors as a First-Line Option for Preventive Treatment of Migraine: New American Headache Society Consensus Statement.
- Published in:
- Patient Care (Online), 2024, p. 1
- By:
- Publication type:
- Article
Atogepant vs Rimegepant for Migraine Prevention: Daily Dose.
- Published in:
- Patient Care (Online), 2024, p. 1
- By:
- Publication type:
- Article
Calcitonin gene‐related peptide‐targeting therapies are a first‐line option for the prevention of migraine: An American Headache Society position statement update.
- Published in:
- Headache: The Journal of Head & Face Pain, 2024, v. 64, n. 4, p. 333, doi. 10.1111/head.14692
- By:
- Publication type:
- Article
A large language model–based generative natural language processing framework fine‐tuned on clinical notes accurately extracts headache frequency from electronic health records.
- Published in:
- Headache: The Journal of Head & Face Pain, 2024, v. 64, n. 4, p. 400, doi. 10.1111/head.14702
- By:
- Publication type:
- Article
Efficacy of Probiotics in Prevention of Migraine Attacks in Children: A Randomized Clinical Trial Study.
- Published in:
- Iranian Journal of Child Neurology, 2024, v. 18, n. 2, p. 103, doi. 10.22037/ijcn.v17i4.39598
- By:
- Publication type:
- Article
Glymphatic and Lymphatic Functions in Patients with Chronic Migraine.
- Published in:
- Neurology Alert, 2024, v. 43, n. 8, p. 1
- Publication type:
- Article
Structural equation modeling for identifying the drivers of health-related quality of life improvement experienced by patients with migraine receiving eptinezumab.
- Published in:
- Journal of Headache & Pain, 2024, v. 25, n. 1, p. 1, doi. 10.1186/s10194-024-01752-z
- By:
- Publication type:
- Article
Is erenumab an efficient alternative for the prevention of episodic and chronic migraine in Spain? Results of a cost-effectiveness analysis.
- Published in:
- Journal of Headache & Pain, 2024, v. 25, n. 1, p. 1, doi. 10.1186/s10194-024-01747-w
- By:
- Publication type:
- Article
Safety and tolerability of atogepant for the preventive treatment of migraine: a post hoc analysis of pooled data from four clinical trials.
- Published in:
- Journal of Headache & Pain, 2024, v. 25, n. 1, p. 1, doi. 10.1186/s10194-024-01736-z
- By:
- Publication type:
- Article
AMPK activation attenuates central sensitization in a recurrent nitroglycerin-induced chronic migraine mouse model by promoting microglial M2-type polarization.
- Published in:
- Journal of Headache & Pain, 2024, v. 25, n. 1, p. 1, doi. 10.1186/s10194-024-01739-w
- By:
- Publication type:
- Article
Atogepant Safe, Effective in Treatment-Resistant Episodic Migraine: Daily Dose.
- Published in:
- Patient Care (Online), 2024, p. 1
- By:
- Publication type:
- Article
Blood pressure elevation in erenumab‐treated patients with migraine: A retrospective real‐world experience.
- Published in:
- Headache: The Journal of Head & Face Pain, 2024, v. 64, n. 3, p. 233, doi. 10.1111/head.14679
- By:
- Publication type:
- Article
Correction to: "Once‐daily oral atogepant for the long‐term preventive treatment of migraine: Findings from a multicenter, randomized, open‐label, phase 3 trial".
- Published in:
- 2024
- Publication type:
- Correction Notice
Migraine headaches are associated with motor vehicle crashes and driving habits among older drivers: Prospective cohort study.
- Published in:
- Journal of the American Geriatrics Society, 2024, v. 72, n. 3, p. 791, doi. 10.1111/jgs.18719
- By:
- Publication type:
- Article
Early and annual projected savings from anti-CGRP monoclonal antibodies in migraine prevention: a cost-benefit analysis in the working-age population.
- Published in:
- Journal of Headache & Pain, 2024, v. 25, n. 1, p. 1, doi. 10.1186/s10194-024-01727-0
- By:
- Publication type:
- Article
Effect of galcanezumab in women with episodic migraine meeting criteria for menstrually related migraine: A post hoc analysis of EVOLVE‐1 and EVOLVE‐2.
- Published in:
- Headache: The Journal of Head & Face Pain, 2024, v. 64, n. 2, p. 179, doi. 10.1111/head.14652
- By:
- Publication type:
- Article
The introduction of the CGRP monoclonal antibodies and their effect on the prescription patterns of chronic migraine preventive medications in a tertiary headache center: A retrospective, observational analysis.
- Published in:
- Headache: The Journal of Head & Face Pain, 2024, v. 64, n. 2, p. 188, doi. 10.1111/head.14642
- By:
- Publication type:
- Article
Acupuncture mechanisms in migraine revealed.
- Published in:
- Journal of Chinese Medicine (JCM), 2024, n. 134, p. 78
- Publication type:
- Article
Health equity, care access and quality in headache – part 1.
- Published in:
- Journal of Headache & Pain, 2024, v. 25, n. 1, p. 1, doi. 10.1186/s10194-024-01712-7
- By:
- Publication type:
- Article
Anti-CGRP antibody galcanezumab modifies the function of the trigeminovascular nocisensor complex in the rat.
- Published in:
- Journal of Headache & Pain, 2024, v. 25, n. 1, p. 1, doi. 10.1186/s10194-024-01717-2
- By:
- Publication type:
- Article
Real-World Effectiveness of Calcitonin Gene--Related Peptide-Binding Monoclonal Antibodies for Migraine Prevention: A Systematic Review.
- Published in:
- Canadian Journal of Hospital Pharmacy / Journal Canadien de la Pharmacie Hospitalière, 2024, v. 77, n. 1, p. 1, doi. 10.4212/cjhp.3382
- By:
- Publication type:
- Article
Characteristics associated with response to subcutaneously administered anti‐CGRP monoclonal antibody medications in a real‐world community cohort of persons living with migraine: A retrospective clinical and genetic study.
- Published in:
- Headache: The Journal of Head & Face Pain, 2024, v. 64, n. 1, p. 68, doi. 10.1111/head.14655
- By:
- Publication type:
- Article
Comparative prevalence and characteristics of fabricated citations in large language models in headache medicine.
- Published in:
- Headache: The Journal of Head & Face Pain, 2024, v. 64, n. 1, p. 93, doi. 10.1111/head.14638
- By:
- Publication type:
- Article
A retrospective analysis of the use of candesartan for migraine prevention in adolescents.
- Published in:
- Headache: The Journal of Head & Face Pain, 2024, v. 64, n. 1, p. 96, doi. 10.1111/head.14666
- By:
- Publication type:
- Article
Recognising and managing migraine.
- Published in:
- Nursing Standard, 2024, v. 39, n. 1, p. 76, doi. 10.7748/ns.2023.e12059
- By:
- Publication type:
- Article
Compromised trigemino-coerulean coupling in migraine sensitization can be prevented by blocking beta-receptors in the locus coeruleus.
- Published in:
- Journal of Headache & Pain, 2023, v. 24, n. 1, p. 1, doi. 10.1186/s10194-023-01691-1
- By:
- Publication type:
- Article
Clinical effectiveness of pharmacological interventions for managing chronic migraine in adults: a systematic review and network meta-analysis.
- Published in:
- Journal of Headache & Pain, 2023, v. 24, n. 1, p. 1, doi. 10.1186/s10194-023-01696-w
- By:
- Publication type:
- Article
Evaluation of Safety and Efficacy of Add‐on Alpha‐Lipoic Acid on Migraine Prophylaxis in an Adolescent Population: A Randomized Controlled Trial.
- Published in:
- Journal of Clinical Pharmacology, 2023, v. 63, n. 12, p. 1398, doi. 10.1002/jcph.2331
- By:
- Publication type:
- Article
The Ketogenic Diet in the Prevention of Migraines in the Elderly.
- Published in:
- Nutrients, 2023, v. 15, n. 23, p. 4998, doi. 10.3390/nu15234998
- By:
- Publication type:
- Article
Long-term effectiveness of eptinezumab in patients with migraine and prior preventive treatment failures: extension of a randomized controlled trial.
- Published in:
- Journal of Headache & Pain, 2023, v. 24, n. 1, p. 1, doi. 10.1186/s10194-023-01688-w
- By:
- Publication type:
- Article
Treatment patterns for patients initiating novel acute migraine specific medications (nAMSMs) in the context of monoclonal antibodies (mAbs) targeting the calcitonin gene-related peptide (CGRP) pathway.
- Published in:
- Journal of Headache & Pain, 2023, v. 24, n. 1, p. 1, doi. 10.1186/s10194-023-01678-y
- By:
- Publication type:
- Article
One-year prospective real-world assessment of effectiveness and safety of erenumab in migraine prevention: results of the French FHU INOVPAIN registry study.
- Published in:
- Journal of Headache & Pain, 2023, v. 24, n. 1, p. 1, doi. 10.1186/s10194-023-01680-4
- By:
- Publication type:
- Article
Effects of Introvision, a self-regulation method with a mindfulness-based perception technique in migraine prevention: a monocentric randomized waiting-list controlled study (IntroMig Study).
- Published in:
- Journal of Headache & Pain, 2023, v. 24, n. 1, p. 1, doi. 10.1186/s10194-023-01684-0
- By:
- Publication type:
- Article
Ultrasound-Guided combined greater occipital nerve block at the C2 level with trapezius trigger point injection and supraorbital-Supratrochlear nerve block: More effective on allodynia and disability in chronic migraine.
- Published in:
- Annals of Indian Academy of Neurology, 2023, v. 26, n. 6, p. 943, doi. 10.4103/aian.aian_677_23
- By:
- Publication type:
- Article
Response to the letter to the editor by Treleaven et al., May 14, 2023.
- Published in:
- 2023
- By:
- Publication type:
- Letter to the Editor
Journal scan.
- Published in:
- Gastrointestinal Nursing, 2023, v. 21, n. 9, p. 10, doi. 10.12968/gasn.2023.21.9.10
- By:
- Publication type:
- Article
Numbers needed to treat or harm and likelihood of being helped versus harmed for fremanezumab in patients who had prior inadequate response to two to four classes of migraine preventive medications: A post hoc analysis.
- Published in:
- Headache: The Journal of Head & Face Pain, 2023, v. 63, n. 10, p. 1351, doi. 10.1111/head.14651
- By:
- Publication type:
- Article
Sustained response of galcanezumab in migraine prevention: Patient‐level data from a post hoc analysis in patients with episodic or chronic migraine.
- Published in:
- Headache: The Journal of Head & Face Pain, 2023, v. 63, n. 10, p. 1380, doi. 10.1111/head.14494
- By:
- Publication type:
- Article